CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on April 25, 2012
OPKO
April 25, 2012
Via: EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Re: | OPKO Health, Inc. |
Post-Effective Amendment No. 1 to |
Registration Statement on Form S-1 (File No. 333-177962) |
Ladies and Gentlemen:
OPKO Health, Inc. (the Company) hereby requests that the effective date of the above-mentioned Registration Statement be accelerated so that the Registration Statement shall become effective at 4:00 P.M. on April 26, 2012, or as soon thereafter as practicable.
The Company acknowledges that (i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
OPKO Health, Inc. |
||
By: | /s/ Rao Uppaluri | |
Rao Uppaluri | ||
Senior Vice President, Chief Financial Officer |